Advertisement

Erratum

        Erratum to: “Deep Brain Stimulation of the Substantia Nigra Pars Reticulata for Treatment-Resistant Schizophrenia: A Case Report,” by Cascella et al. (Biol Psychiatry 2021; 90:e57–e59); https://doi.org/10.1016/j.biopsych.2021.03.007.
        The authors inadvertently used an incorrect unit of measure for voltage. Specifically, throughout the paper, the unit mV should instead have been V. This error has been corrected in the article.

        Linked Article

        • Deep Brain Stimulation of the Substantia Nigra Pars Reticulata for Treatment-Resistant Schizophrenia: A Case Report
          Biological PsychiatryVol. 90Issue 10
          • Preview
            Deep brain stimulation (DBS) is an effective treatment for Parkinson’s disease (1) via modulation of motor corticostriatothalamic circuits (CSTs) (2,3). CST connections to motor, limbic, and associative cortices are also promising DBS targets for Tourette syndrome, obsessive-compulsive disorder (4), and major depression (5–8). Schizophrenia (SZ) is a disorder with disruptions in limbic and associative CSTs (9,10). One-fifth to one-half of SZ patients are treatment resistant (TR). DBS targeted at basal ganglia structures within limbic and associative CSTs could have the potential to alleviate TR SZ symptoms.
          • Full-Text
          • PDF